Cardiovascular disease risk after breast cancer treatment in patients with a BRCA1/2 pathogenic variant. Terra L, Boekel NB, Hooning MH, Collee M, et al. Breast Cancer Res Treat 2024 Oct 31. doi: 10.1007/s10549-024-07516.

Read + Share

Amedeo Smart

Independent Medical Education

Terra L, Boekel NB, Hooning MH, Collee M, et al. Cardiovascular disease risk after breast cancer treatment in patients with a BRCA1/2 pathogenic variant. Breast Cancer Res Treat 2024 Oct 31. doi: 10.1007/s10549-024-07516.
PMID: 39482556